Multi-Target Analysis of Xanthone Derivatives as Potential Anti-Trypanosoma cruzi Agents: An Integrated Computational Screening
In silico results highlight XN5 as a promising candidate for Chagas disease treatment, showing multi-parameter optimization scores of 5, molecular weights below 400 g/mol, and advantageous absorption and permeability profiles.